ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease

Published 2018 View Full Article

Authors

Keywords

Journal

BRAIN RESEARCH BULLETIN

Volume 137, Issue -, Pages 265-276

Publisher

Elsevier BV

Online

2018-01-05

DOI

10.1016/j.brainresbull.2018.01.001

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

BRAIN RESEARCH BULLETIN

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.